ondasdechoque.org
PT-BR

Chronic lower-limb wounds · Comparison study · 2008

Can shockwave help long-standing leg wounds close?

In this study, half of the long-standing leg wounds treated with shockwave closed completely (16 of 32), within 4 to 6 sessions. In a separate group treated with dressings alone, 1 of 10 wounds closed over 8 weeks. Pain eased a little in both groups.

people with long-standing leg wounds
40
shockwave sessions, 2 weeks apart
4–10
kinds of wound: after injury, vein-related and diabetic
3

Good to know: Groups were not assigned at random and were followed for different lengths of time; wounds, not people, were counted.

Saggini R, Figus A, Troccola A, et al. Ultrasound Med Biol, 2008 · Read the paper ↗

How this study worked

Shockwave + dressings30 peopleDressings alone10 people
Groups were compared, but people were not assigned to them by lot. Each dot is one person.

The treatment

Shockwave + dressings

Focused

Focused wavesMeet at a focal zone below the skin
Pulses
100 per area · each cm² of wound
Strength
0.037mJ/mm² · 4 per second
Numbing
None
Device
Evotron/Trode
Everyone also got
Their usual dressings and pain medicines, unchanged

Compared with: Regular dressings alone, in a separate group of 10 people

Settings are what each study used, not a prescription.

Who took part

40 people with long-standing leg wounds after injury, from vein problems or from diabetes: 30 had shockwave (32 wounds) and 10 dressings only.

Shockwave + dressings30 people
Dressings alone10 people

Side effects

Eight people felt a brief, slight rise in pain during some sessions. No bleeding or bruising was reported. One wound that would not heal turned out to have a bone infection and needed surgery.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

30 ESWT patients with 32 wounds and 10 dressing-control patients with 10 wounds; traumatic, venous and diabetic etiologies.

Shockwave treatment30enrolled

Participant counts; outcome-specific denominators remain in each panel.

Control10enrolled

Participant counts; outcome-specific denominators remain in each panel.

Complete wound closure1 reported outcome
01
ESWT 4–6 sessions; control 8 weeks

Complete wound closure

Complete wound closure wounds

Complete closure: 16/32 ESWT wounds versus 1/10 control wounds. Denominators are wounds, not participants; unequal assessment windows and nonrandomized allocation.

Analysis details and source

Complete closure: 16/32 ESWT wounds versus 1/10 control wounds. Denominators are wounds, not participants; unequal assessment windows and nonrandomized allocation.

Numeric box pain score1 reported outcome
02
After the ESWT course (4–10 sessions); control after 8 weeks of dressings

Numeric box pain score

Numeric box pain score points, 0–10

means
GroupnBaselineFollow-up
Shockwave treatment——5.03
Control——5.5

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

Baseline 6.65 and 6.2; reported ESWT within-group p<.001 is not a treatment contrast; table rows may repeat bilateral patients. The Results also report a Wilcoxon matched-pairs test applied to the differences between the two groups (p < 0.01, one value given jointly for wound area, granulation tissue and pain); the paper does not explain how two unpaired groups of unequal size were matched.

Analysis details and source

Baseline 6.65 and 6.2; reported ESWT within-group p<.001 is not a treatment contrast; table rows may repeat bilateral patients. The Results also report a Wilcoxon matched-pairs test applied to the differences between the two groups (p < 0.01, one value given jointly for wound area, granulation tissue and pain); the paper does not explain how two unpaired groups of unequal size were matched.

Wound area and wound-bed changes1 reported outcome
03
Reported follow-up

Wound area and wound-bed changes

Wound area and wound-bed changes wounds and percentage area change

Among unhealed treated wounds, mean area reduction was 37.5% (22–60%) for traumatic wounds, 45% (32–70%) for venous wounds and 50% for diabetic wounds. Granulation and exudate improved (reported p<.01); control baseline-to-eight-week changes were nonsignificant. Closure by cause was 11/16 traumatic, four venous and 1/4 diabetic wounds. The venous denominator is inconsistent (11 versus 12) in the source; no corrected percentage is inferred.

Analysis details and source

Among unhealed treated wounds, mean area reduction was 37.5% (22–60%) for traumatic wounds, 45% (32–70%) for venous wounds and 50% for diabetic wounds. Granulation and exudate improved (reported p<.01); control baseline-to-eight-week changes were nonsignificant. Closure by cause was 11/16 traumatic, four venous and 1/4 diabetic wounds. The venous denominator is inconsistent (11 versus 12) in the source; no corrected percentage is inferred.

How treatment was delivered
Reported protocol

Evotron with hand-held Trode probes (focal volume 10–15 mm in diameter); 100 impulses/cm², 0.037 mJ/mm², 4 Hz, 4–10 sessions every 2 weeks; no anesthesia. Gauze/gel contact; prior dressings and stable analgesics continued.

HARMS & TOLERABILITY

Eight treated patients reported transient one-point pain increases during some sessions; six reported no pain improvement after treatment. No bleeding, petechiae, hematoma or seroma reported. One resistant wound proved to have osteomyelitis requiring surgery.

LIMITS OF THE ANALYSIS

Unclear allocation, unequal follow-up and different etiologies prevent a causal estimate. Wounds outnumber patients; no clustering correction described. Text alternates 11/12 venous ulcers and tables contain dimension/area discrepancies. No formal economic evaluation supports cost-effectiveness wording; no explicit conflict statement located.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Unclear allocation, unequal follow-up and different etiologies prevent a causal estimate. Wounds outnumber patients; no clustering correction described. Text alternates 11/12 venous ulcers and tables contain dimension/area discrepancies. No formal economic evaluation supports cost-effectiveness wording; no explicit conflict statement located.
Research review

Source-linked critical reading

Nonrandomized comparisons

Reading depthMaterial consulted
Technical source record

Full source read: body, methods, results, all tables and figure captions, discussion and references; the article prints no disclosures section and refers to no supplementary material.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Nonrandomized comparative study of 30 treated patients with 32 wounds and 10 control patients with 10 wounds, with unequal observation windows.

Participants and setting

30 ESWT patients with 32 wounds and 10 dressing-control patients with 10 wounds; traumatic, venous and diabetic etiologies.

Treatment delivered

Focused ESWT every two weeks, 4–10 sessions, with prior wound care continued.

What was compared

Ten separately recruited controls received regular dressings for 8 weeks; random treatment allocation is not established.

Outcomes and timing

The extracted panels retain the original outcome units and assessment times. 16/32 treated wounds closed, versus 1/10 controls at 8 weeks. Treated wounds closed within 4–6 sessions; additional sessions up to 10 gave little further benefit. Pain fell from 6.65 to 5.03, versus 6.2 to 5.5 in controls.

Results in context

16/32 treated wounds closed, versus 1/10 controls at 8 weeks. Treated wounds closed within 4–6 sessions; additional sessions up to 10 gave little further benefit. Pain fell from 6.65 to 5.03, versus 6.2 to 5.5 in controls.

Harms and tolerability

Eight treated patients reported transient one-point pain increases during some sessions; six reported no pain improvement after treatment. No bleeding, petechiae, hematoma or seroma reported. One resistant wound proved to have osteomyelitis requiring surgery.

Limits and disclosures

Unclear allocation, unequal follow-up and different etiologies prevent a causal estimate. Wounds outnumber patients; no clustering correction described. Text alternates 11/12 venous ulcers and tables contain dimension/area discrepancies. No formal economic evaluation supports cost-effectiveness wording; no explicit conflict statement located.

Clinical applicability

Suggests feasibility after failed dressings, but posttraumatic, venous and diabetic wounds should not be combined into a universal success probability.

What a next study should resolve

Randomize patients to identical wound care with active or sham treatment, use common assessment times and account for multiple wounds per patient while separating wound etiologies.

THE ORIGINAL SOURCE

Read the original article.

Extracorporeal Shock Wave Therapy for Management of Chronic Ulcers in the Lower Extremities

Saggini R, Figus A, Troccola A, Cocco V, Saggini A, Scuderi N. · Ultrasound Med Biol · 2008

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →